JOSHUA CHAMBERS: Open Payments
NPI 1518409630 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$207 in 9 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $133 · 2025 $207
Food & beverage: $207
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 2 | $45 |
| Novartis Pharmaceuticals Corporation | 2 | $35 |
| Geron Corporation | 1 | $32 |
| ABIOMED | 1 | $32 |
| Emmaus Medical, Inc. | 1 | $26 |
| Janssen Biotech, Inc. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: KEYTRUDA, KISQALI, RYTELO, Endari, TALVEY, LYNPARZA.
Industry payments across IN — which companies pay providers there.
